Corporate Board Profile
Tech Score: 17/100
1 mention(s) identify MICHAEL S. PERRY as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | 2012-01-12 | From 2002 to 2003, Dr. Perry served as President and Chief Executive Officer of Pharsight Corporation, a publicly held software and consulting services firm. | Served as President and CEO of Pharsight Corporation, a publicly held software and consulting services firm, indicating experience with software-related technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2012-01-12 | From 2002 to 2003, Dr. Perry served as President and Chief Executive Officer of Pharsight Corporation, a publicly held software and consulting services firm. |
| 2013-02-04 | Dr. Perry holds a Doctor of Veterinary Medicine, a Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. ... We believe Dr. Perry’s qualifications to serve on the board include his medical expertise and his extensive experience in preclinical and clinical drug development, including executive level leadership roles in several publicly held biotech companies. |
| 2013-12-20 | Dr. Perry holds a Doctor of Veterinary Medicine, a Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. |
| 2015-01-23 | Dr. Perry holds a Doctor of Veterinary Medicine, a Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics... extensive experience in preclinical and clinical drug development. |
| 2016-01-19 | Dr. Perry holds a Doctor of Veterinary Medicine, a Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. He is a graduate of the International Management Program at Harvard Business School. We believe Dr. Perry’s qualifications to serve on the board include his medical expertise and his extensive experience in preclinical and clinical drug development, including executive level leadership roles in several publicly held biotech companies. |
| 2017-02-01 | Dr. Perry holds a Doctor of Veterinary Medicine, a Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. He is a graduate of the International Management Program at Harvard Business School. |
Data sourced from SEC filings. Last updated: 2025-08-30